[
  {
    "ts": null,
    "headline": "Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris",
    "summary": "SDZNY, TEVA, and VTRS show resilience with strong biosimilar pipelines and margin strategies amid industry headwinds.",
    "url": "https://finnhub.io/api/news?id=24d9c6ff2307b645dcca57f1c345a1f70c13dd32ca0d656f528fba6e57764fd5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749546000,
      "headline": "Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris",
      "id": 135149480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "SDZNY, TEVA, and VTRS show resilience with strong biosimilar pipelines and margin strategies amid industry headwinds.",
      "url": "https://finnhub.io/api/news?id=24d9c6ff2307b645dcca57f1c345a1f70c13dd32ca0d656f528fba6e57764fd5"
    }
  }
]